封面
市場調查報告書
商品編碼
1691710

馬匹醫療保健市場 - 全球產業規模、佔有率、趨勢、機會和預測,按產品、適應症、活動、配銷通路、地區和競爭細分,2020-2030 年

Equine Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Activity, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球馬匹醫療保健市場價值為 35.8 億美元,預計到 2030 年將達到 57.7 億美元,複合年成長率為 8.26%。隨著人們對馬匹健康管理認知的提高和對獸醫護理的投資增加,全球馬匹醫療保健市場正在穩步成長。隨著馬主、飼養者和馬術專業人士越來越重視動物福利,對預防性醫療保健解決方案(包括疫苗、驅蟲藥和先進的診斷工具)的需求也日益增加。擴大採用技術先進的監測設備和穿戴式感測器進行即時健康狀況追蹤,改變了馬匹的醫療保健實踐。該行業也見證了專門的馬匹保險政策的激增,使得先進的治療變得更加容易獲得。馬匹復健中心和再生醫學療法(如幹細胞和富血小板血漿治療)的出現進一步促進了市場擴張。

市場概況
預測期 2026-2030
2024 年市場規模 35.8 億美元
2030 年市場規模 57.7 億美元
2025-2030 年複合年成長率 8.26%
成長最快的領域 診斷
最大的市場 北美洲

推動市場發展的是針對馬科動物的獸藥、營養和疾病管理解決方案的進步。馬疾病(包括呼吸道疾病、蹄葉炎和傳染病)的發生率日益上升,推動了對創新治療方案的需求。越來越多的人參與馬術運動和比賽,這也推動了對表現監測、傷害預防和骨科護理的需求。遠距醫療和基於人工智慧的診斷平台等數位健康解決方案的採用正在提高獸醫諮詢和治療效率。政府支持馬病控制和生物安全措施的措施也在市場成長中發揮至關重要的作用。

該行業面臨的挑戰與先進的馬匹醫療費用高昂以及偏遠地區獲得專門獸醫護理的機會有限有關。有關馬藥核准和動物福利政策的嚴格規定影響了新保健產品的商業化。對假獸藥的擔憂以及提高診斷準確性的需求帶來了額外的障礙。控制馬群中的傳染病爆發仍然是一個關鍵問題,需要加強生物安全措施和疫苗接種計劃。該市場為個人化馬匹營養、穿戴式健康監測設備和再生療法的創新提供了機會,預計將推動長期成長。

主要市場促進因素

馬術運動和活動的參與度不斷提高

主要市場挑戰

專科護理費用高昂

主要市場趨勢

精準醫療和個人化護理

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第 4 章:顧客之聲

第5章:全球馬匹保健市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症分類(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、娛樂、其他)
    • 依配銷通路(獸醫院及診所、電子商務、其他)
    • 按公司分類(2024)
    • 按地區
  • 市場地圖

第6章:北美馬匹保健市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 墨西哥
    • 加拿大

第7章:歐洲馬匹保健市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章:亞太馬匹保健市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章:南美洲馬匹保健市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲馬匹保健市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 合併與收購(如有)
  • 產品發布(如果有)
  • 最新動態

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章:競爭格局

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Hallmarq Veterinary Imaging Ltd
  • Esaote SpA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Arthrex Inc.
  • Heska Corporation

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17486

Global Equine Healthcare Market was valued at USD 3.58 Billion in 2024 and is expected to reach USD 5.77 Billion in the forecast period with a CAGR of 8.26% through 2030. The Global Equine Healthcare Market is experiencing steady growth due to rising awareness about equine health management and increasing investments in veterinary care. The demand for preventive healthcare solutions, including vaccines, dewormers, and advanced diagnostic tools, is expanding as horse owners, breeders, and equestrian professionals prioritize animal welfare. The growing adoption of technologically advanced monitoring devices and wearable sensors for real-time health tracking has transformed equine healthcare practices. The industry is also witnessing a surge in specialized equine insurance policies, making advanced treatments more accessible. The emergence of equine rehabilitation centers and regenerative medicine therapies such as stem cell and platelet-rich plasma treatments is further contributing to market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.58 Billion
Market Size 2030USD 5.77 Billion
CAGR 2025-20308.26%
Fastest Growing SegmentDiagnostics
Largest MarketNorth America

The market is driven by advancements in veterinary pharmaceuticals, nutrition, and disease management solutions tailored for equine species. The increasing prevalence of equine diseases, including respiratory disorders, laminitis, and infectious conditions, is pushing the demand for innovative treatment options. Rising participation in equestrian sports and racing is fueling the need for performance monitoring, injury prevention, and orthopedic care. The adoption of digital health solutions, such as telemedicine and AI-based diagnostic platforms, is enhancing veterinary consultations and treatment efficiency. Government initiatives supporting equine disease control and biosecurity measures are also playing a crucial role in market growth.

The industry faces challenges related to the high costs associated with advanced equine medical treatments and limited access to specialized veterinary care in remote areas. Stringent regulations governing equine drug approvals and animal welfare policies impact the commercialization of new healthcare products. Concerns over counterfeit veterinary drugs and the need for improved diagnostic accuracy pose additional hurdles. Managing infectious disease outbreaks in equine populations remains a critical issue, requiring enhanced biosecurity measures and vaccination programs. The market presents opportunities for innovation in personalized equine nutrition, wearable health monitoring devices, and regenerative therapies, which are expected to drive long-term growth.

Key Market Drivers

Rising Participation in Equestrian Sports and Activities

Equestrian sports and activities have a rich history that spans centuries, from the historic races of ancient Greece to the modern arenas of Olympic dressage. What was once a niche interest has now evolved into a global phenomenon, with millions of enthusiasts participating in various equestrian disciplines. This surge in equestrian engagement is not only shaping the sports landscape but also driving the growth of the global equine healthcare market.

As equestrian sports gain prominence, more people are investing in horse ownership. In the United States alone, the horse population was reported to be over 10.6 million in both 2020 and 2021, accounting for 18% of the world's equine population. Whether for competitive riding, leisure, or companionship, this rise in horse ownership creates a significant demand for equine healthcare services and products. Horse owners, recognizing the need to ensure the health and well-being of their equine partners, are fueling the growth of the equine healthcare market.

The growing equestrian community has fostered increased awareness of equine health and the importance of preventative measures. Horse owners, riders, and trainers understand that regular veterinary check-ups, vaccinations, and proper nutrition are essential to keeping their horses in peak condition. This heightened awareness drives the demand for equine healthcare solutions and encourages a proactive approach to horse care.

Key Market Challenges

High Cost of Specialized Care

The high cost of specialized care presents a significant challenge in the global equine healthcare market. Horses require extensive medical attention, including routine check-ups, vaccinations, dental care, and emergency treatments. When specialized care such as orthopedic surgeries, regenerative therapies, or advanced diagnostic imaging is needed, expenses rise considerably. Veterinary specialists trained in equine medicine often charge premium fees due to the complexity of procedures and the need for specialized equipment. Many horse owners struggle with these costs, especially those involved in non-commercial horse ownership or small-scale equestrian businesses.

Equine healthcare is further complicated by the need for ongoing treatments. Chronic conditions such as musculoskeletal disorders, respiratory issues, and metabolic diseases require long-term management, which leads to continuous financial burdens. Advanced treatments like stem cell therapy, laser therapy, and MRI scans can be prohibitively expensive, limiting access to necessary medical interventions. Insurance coverage for equine healthcare is not as widely available or comprehensive as human health insurance, making it difficult for owners to afford specialized care without significant out-of-pocket expenses.

The rising cost of equine healthcare has also impacted equestrian sports and breeding programs. Competitive horses require top-tier medical care to maintain performance and prevent injuries. When specialized care becomes unaffordable, it leads to compromised treatment quality, potential neglect, or premature retirement of horses from competitions. In breeding programs, high veterinary costs affect reproductive health management, including artificial insemination and embryo transfer services. Without affordable specialized care, the long-term sustainability of horse ownership and equine-related industries remains a challenge. Addressing these cost concerns through innovative financing options, insurance expansion, and technological advancements in affordable treatments is crucial for supporting the growth of the equine healthcare market.

Key Market Trends

Precision Medicine and Personalized Care

The global equine healthcare market is witnessing a shift toward precision medicine and personalized care, driven by advancements in veterinary diagnostics, genomics, and data-driven treatment approaches. Precision medicine focuses on tailoring healthcare solutions based on the specific genetic, physiological, and environmental factors of each horse. Veterinarians are leveraging genomic testing and biomarker analysis to develop individualized treatment plans, ensuring more effective disease management and preventive care. Genetic profiling enables early detection of predispositions to conditions such as laminitis, musculoskeletal disorders, and respiratory diseases, allowing for targeted interventions before clinical symptoms emerge. Personalized nutrition plans, based on metabolic profiling, are helping optimize horse health, performance, and longevity.

Wearable health-monitoring devices and telemedicine solutions are enhancing personalized care by continuously tracking vital parameters, including heart rate, temperature, and gait patterns. These real-time insights allow early detection of health abnormalities, reducing the risk of severe illnesses and costly medical interventions. Equine athletes benefit from customized rehabilitation programs, integrating physiotherapy, regenerative medicine, and laser therapy tailored to their specific recovery needs. The adoption of stem cell and gene therapy is further revolutionizing treatment strategies by offering regenerative solutions customized to the genetic makeup and condition of individual horses.

Key Market Players

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Hallmarq Veterinary Imaging Ltd
  • Esaote SpA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Arthrex Inc.
  • Heska Corporation

Report Scope:

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product:

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

Equine Healthcare Market, By Indication:

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

Equine Healthcare Market, By Activity:

  • Sports/Racing
  • Recreation
  • Others

Equine Healthcare Market, By Distribution Channel:

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Equine Healthcare Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

Global Equine Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Equine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Activity
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Activity
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Mexico Equine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Activity
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Canada Equine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Activity
        • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Activity
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Equine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Activity
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Equine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Activity
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Equine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Activity
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Equine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Activity
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Equine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Activity
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Equine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Activity
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Equine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Activity
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Equine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Activity
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. South Korea Equine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Activity
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Japan Equine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Activity
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Equine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Activity
        • 8.3.5.2.4. By Distribution Channel

9. South America Equine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Activity
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Equine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Activity
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Equine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Activity
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Equine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Activity
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Equine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Activity
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Equine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Activity
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Equine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Activity
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Equine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Activity
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Zoetis Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Boehringer Ingelheim GmbH
  • 14.3. Merck & Co., Inc.
  • 14.4. Hallmarq Veterinary Imaging Ltd
  • 14.5. Esaote SpA
  • 14.6. Vetoquinol SA
  • 14.7. IDEXX Laboratories, Inc.
  • 14.8. Dechra Pharmaceuticals PLC
  • 14.9. Arthrex Inc.
  • 14.10. Heska Corporation

15. Strategic Recommendations

16. About Us & Disclaimer